VA launches five-site PIVOT trial of COMP360 psilocybin for veterans with treatment-resistant depression
Psychedelic Policy Briefing 8.14.26
The U.S. Department of Veterans Affairs launched PIVOT on August 5, a five-site trial of Compass Pathways' COMP360 psilocybin in veterans with treatment-resistant depressiontreatment-resistant depressionDepression that has not improved enough after adequate courses of at least two antidepressant treatments.Open the glossary.
Key facts
- Kind of item
- Guidance and consultations
- Compound
- Psilocybin
- Condition
- Depression
- Organisation
- Compass Pathways
- Jurisdiction
- United States
- Source
- Lucid News (lucid.news)
- Published
- Original
- Read it at lucid.news
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Lucid News · lucid.news
Connected to
- Kind of item
- Guidance and consultations
- Compound
- Psilocybin
- Condition
- Depression
- Organisation
- Compass Pathways
- Jurisdiction
- United States